Avenue Therapeutics Inc.

NASDAQ: ATXIHealthcare / Drug Manufacturers - Other / -
6.06-0.4700-7.20%Vol 72 9481Y Perf 51.45%
Jun 24th, 2019 16:00
BID6.08 ASK6.21
Open6.30 Previous Close6.53
Pre-Market- After-Trading-
 - -%  - -%
Target Price
13.67 
Analyst Rating
Strong Buy 1.00
Potencial %
125.58 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)100 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
67.46 
Earnings Date
13th Aug 2019

Today's Price Range

6.066.39

52wk Range

2.087.98

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
27.58%
3 Months
10.18%
6 Months
18.82%
1 Year
51.45%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
ATXI6.06-0.4700-7.20
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.44-0.82-86.36
Q04 2018-0.47-0.3819.15
Q03 2018-0.35-0.2528.57
Q02 2018-0.72-0.4537.50
Q01 2018-0.68-1.03-51.47
----
----
----
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.56-7.69Negative
9/2019 QR-0.2712.90Positive
12/2019 FY-1.82-10.98Negative
12/2020 FY-0.98-6.52Negative
Next Report Date13th Aug 2019
Estimated EPS Next Report-0.56
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume72 948
Shares Outstanding (in ths.)16 559
Trades Count326
Dollar Volume401 376
Avg. Volume54 770
Avg. Weekly Volume70 967
Avg. Monthly Volume155 087
Avg. Quarterly Volume62 104
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Avenue Therapeutics Inc.

Avenue Therapeutics Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain. The company's primary objective is to establish IV Tramadol as an invaluable part of a treating physician's repertoire of available pharmaceutical options for the management of postoperative pain.

CEO: Lucy Lu

Teplephone: +1 781 652-4500

Address: 2 Gansevoort Street, New York 10014, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

17%83%

Bearish Bullish

56%44%

Bearish Bullish

62%38%

News